salvianolate injection

DRUG4 trials

Sponsors

China Academy of Chinese Medical Sciences, Green Valley Group of China, Xiyuan Hospital of China Academy of Chinese Medical Sciences

Conditions

AnginaAngina, StableSTEMI - ST Elevation Myocardial InfarctionUnstable Angina

Phase 4

Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate Injection

China Academy of Chinese Medical SciencesAngina

Start: 2016-02-29End: 2017-03-31Target: 120Updated: 2016-03-01

Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris

Green Valley Group of ChinaUnstable Angina

Start: 2016-05-11End: 2018-12-31Target: 320Updated: 2017-01-31

Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI

Green Valley Group of ChinaSTEMI - ST Elevation Myocardial Infarction

Start: 2017-01-20End: 2018-12-31Target: 536Updated: 2017-02-07

Unknown Phase

Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin

Xiyuan Hospital of China Academy of Chinese Medical SciencesAngina, Stable

Start: 2017-10-10End: 2018-10-10Target: 18Updated: 2017-10-11

Related Papers

Drug-drug interactions between salvianolate injection and aspirin based on their metabolic enzymes.

2021-01-038 citations

Clinical effectiveness and safety of salvia miltiorrhiza depside salt combined with aspirin in patients with stable angina pectoris: A multicenter, pragmatic, randomized controlled trial.

2020-12-109 citations

A Prospective Randomized Multicenter Controlled Trial on Salvianolate for Treatment of Unstable Angina Pectoris in A Chinese Elderly Population.

2019-10-013 citations

Research on the mechanism of drug-drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model: study protocol for a PK-PD trial.

2018-09-142 citations